Less Invasive Gastric Sleeve May Benefit Type 2s


By: Brenda Neugent

Research has already shown that gastric bypass can ease symptoms of diabetes, but according to a new study, a less-invasive sleeve may also result in benefits for those with type 2 diabetes.

According to a recent study, the use of a duodenal-endoluminal sleeve (DES) – a flexible tube that’s implanted in the small intestine to prevent nutrient absorption in the duodenum – resulted in sustained weight loss, improved glucose tolerance, and better fat metabolism when tested on rats with diabetes.

he DES mimics the health benefits of gastric bypass, but can be removed at any time, researchers said.

Kirk M. Habegger from the University of Cincinnati and colleagues from Germany’s Hemholtz Diabetes Center tested rats that had been implanted with the sleeve against those who had not over a 28-day period, and found that the sleeve led to decreased body weight, improved glucose tolerance, and improved fat metabolism.

“Our preclinical results validate DES as a promising therapeutic approach to diabetes and obesity, which offers reversibility, low risk, low invasiveness, and triple benefits including fat mass loss, glucose, and lipid metabolism improvement which mechanistically may involve increased villus growth in the upper gut,” researchers wrote.

The study appeared in the British medical journal Gut.



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.